Alpelisib Induced Hyperglycemic Ketoacidosis; Broadening the Adverse Effect Profile of an Emerging Cancer Therapy

Introduction: Alpelisib (PIQRAY) is a Phosphatidylinositol 3-Kinase Inhibitor (PIP-3K) recently approved by the united states food and drug administration (FDA) for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, phosphatidylinositol-4,5-bisphosphate 3-kinas...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Prasad, Apurwa, Ali, Faisal S, Thapa, Pratikshya, Tuason, John P W, Kim, Keun Young
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Diabetes Mellitus and Glucose Metabolism
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090103/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.741
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars